Commentary · 30 Jul 2024
Conference abstractPublished 22 Aug 2016
Evolution-informed Biomarker Discovery for Precision Oncology
Arizona State University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
As one of the leading causes of death worldwide, cancer takes millions of lives each year despite of hundreds of billions of dollars spent on patient care. Major concerns have been raised on under-treatment that leads to disease progression and drug resistance, and over-treatment that exposes patients to unnecessary toxicity with little or no benefit. This situation can be significantly improved by precision oncology, in which treatment regime is tailored to each patient for best outcome. However, discovering bona fide biomarkers to help predict cancer outcomes has been a long-standing mission in cancer research. Although “omics” data generated by high-through biotechnologies offer a valuable source from which genetic markers can be identified, distinguishing spurious markers that show fortuitous statistical associations from biologically relevant markers is a grand challenge. Here, we present a novel framework that integrates evolutionary patterns and statistical association with sparse learning algorithms to assist cancer biomarker discovery. Our methods search beyond human genomes to look for signatures in cancer driver genes across mammals and vertebrates, and incorporate these patterns to discover novel drug targets and cancer biomarkers. When applied to predict therapeutic responses for patients with acute myeloid leukemia and to predict metastasis for patients with prostate cancers, this novel approach gave rise to evolution-informed models that reported lower complexity and higher accuracy than uninformed models. The identified genetic markers also have significant implications in tumor progression and embrace potential drug targets.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 18 Oct 2017
In silico approach to biomarker discovery and precision medicine applications pertaining to medical devices
Article · 29 Jun 2024
DNA Methylation Profiling As a Model for Neuro-Oncology Discovery and Precise Diagnostics
Perspective · 2023
DNA Methylation Profiling As a Model for Neuro-Oncology Discovery and Precise Diagnostics
Conference abstract · 2017
BRCA1 discovery to precision oncology: The road ahead
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Li Liu”
